Israel's climatetech field at a crossroads as financing drops - The Tamesis

The 39% decline resembles the international recession in environment innovation financing.

Post Views: 67

Tags

Related Posts

Singapore’s biomedical sector is expected to benefit after a sharp rise in pharmaceutical production, as companies anticipate US trade policy changes.

January 20, 2026

Singapore’s biomedical sector is expected to benefit after a sharp rise in pharmaceutical production, as companies anticipate US trade policy changes.

January 19, 2026

The funding spans four national health priorities.

January 19, 2026

The Tamesis

Leave a Reply Cancel reply

Latest from Blog

Japan’s ruling party set to announce election pledges, consider pause on consumption tax for food

“We’re Going Back to Basics”: What’s Next for YMC

Heavyweights enter Nepal’s electoral race, while some sit out

Beyond bamboo diplomacy: Vietnam’s era of national rise in a volatile world

Cleveland Clinic Abu Dhabi names DAWI as exclusive Kuwait digital partner

In ‘Discipline,’ Larissa Pham Asks: Is the Art We Make Powerful Enough to Heal Us?

Former South Korean PM Han jailed for 23 years in martial law case

IVTM market to reach $2.5b by 2033 as sepsis and stroke fuel surge in medical disposables

Gabrielle Goliath Seeks Legal Action Against Culture Minister

Acne Studios Fall 2026 Menswear Collection

Related Posts

Singapore’s biomedical sector is expected to benefit after a sharp rise in pharmaceutical production, as companies anticipate US trade policy changes.

January 20, 2026

Singapore’s biomedical sector is expected to benefit after a sharp rise in pharmaceutical production, as companies anticipate US trade policy changes.

January 19, 2026

The funding spans four national health priorities.

January 19, 2026

Don't Miss

Singapore’s biomedical sector is expected to benefit after a sharp rise in pharmaceutical production, as companies anticipate US trade policy changes.

Singapore’s biopharmaceutical industry is expected to

Singapore’s biomedical sector is expected to benefit after a sharp rise in pharmaceutical production, as companies anticipate US trade policy changes.

Singapore’s biopharmaceutical industry is expected to